These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10418172)

  • 1. Influence of polymorphism at p53, CYP1A1 and GSTM1 loci on p53 mutation and association of p53 mutation with prognosis in lung cancer.
    Wang YC; Chen CY; Wang HJ; Chen SK; Chang YY; Lin P
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):402-10. PubMed ID: 10418172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer.
    Goto I; Yoneda S; Yamamoto M; Kawajiri K
    Cancer Res; 1996 Aug; 56(16):3725-30. PubMed ID: 8706015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer.
    Kawajiri K; Eguchi H; Nakachi K; Sekiya T; Yamamoto M
    Cancer Res; 1996 Jan; 56(1):72-6. PubMed ID: 8548778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
    Dialyna IA; Miyakis S; Georgatou N; Spandidos DA
    Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk.
    Gsur A; Haidinger G; Hollaus P; Herbacek I; Madersbacher S; Trieb K; Pridun N; Mohn-Staudner A; Vetter N; Vutuc C; Micksche M
    Anticancer Res; 2001; 21(3C):2237-42. PubMed ID: 11501853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) and lung cancer outcome.
    Gonlugur U; Pinarbasi H; Gonlugur TE; Silig Y
    Cancer Invest; 2006; 24(5):497-501. PubMed ID: 16939958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.
    Miller DP; Liu G; De Vivo I; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Res; 2002 May; 62(10):2819-23. PubMed ID: 12019159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
    Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
    Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer].
    Li WY; Lai BT; Zhan XP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1042-5. PubMed ID: 15769360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
    Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
    Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men.
    Li M; Guan TY; Li Y; Na YQ
    Chin Med J (Engl); 2008 Feb; 121(4):305-8. PubMed ID: 18304461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
    Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
    Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses.
    Zhuo WL; Zhang YS; Wang Y; Zhuo XL; Zhu B; Cai L; Chen ZT
    Arch Med Res; 2009 Apr; 40(3):169-79. PubMed ID: 19427967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
    Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
    J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer.
    Tan C; Xu HY; Zhang CY; Zhang H; Chen CM; Zhang WM; Sun XY; Jin YT
    Arch Med Res; 2011 Nov; 42(8):669-76. PubMed ID: 22154617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene.
    Gudmundsdottir K; Tryggvadottir L; Eyfjord JE
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1169-73. PubMed ID: 11700265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.